Rabindra Shivnaraine, PhD, Director of Clinical Pharmacology at Aerys Biosciences, spoke at Outsourcing in Clinical Trials West Coast 2026 during the panel on Emerging Biotech vs. Big Pharma.

Dr. Shivnaraine emphasized the importance of executing First-in-Human trials efficiently, leveraging lean outsourcing models, and building trusted CRO partnerships to accelerate development. Emerging biopharma companies like Aerys operate with focused teams and disciplined execution to move high-quality programs into the clinic quickly and generate meaningful data.